Business
UBS, Minters help Arrotex in $205m McPherson’s bid – The Australian Financial Review
Rich Lister Ruffy Geminder has got a fight on his hands at ASX-listed beauty company and takeover target McPherson’s.
And while McPhersons board said Gallins offer undervalued the company, it said it would give Arrotex access to due diligence information and progress discussions, with a view to developing a transaction to put to shareholders.
Arrotex was formed in 2019, following the merger of Arrow Pharmaceuticals and Apotex Australia. The company supplies generic pharmaceuticals, over the counter products and vitamins to pharmacies around the country.
Meanwhile, McPhersons supplies health, wellness and beauty…
-
Business22 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
Noosa News24 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Business23 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?
-
General18 hours agoMigrants raise concerns over Australia’s English tests for visa applicants